REVNEUZEPriority claimed from 30/07/2019; Application No. : 88550791 ;United States of America (Class 5)
#4252323
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | REVNEUZEPriority claimed from 30/07/2019; Application No. : 88550791 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 4252323 |
| Nature/Scope of business | pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's disease, parkinson's disease, mixed dementia, frontotemporal dementia, dementia with lewy bodies, vascular dementia, wernicke-korsakoff syndrome, huntington's disease, creutzfeldt jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases |
| Publication | In Journal No. 1919 |
| Status | DRAFT |
| Applicant: | PHARMAZZ, INC. |
| Applicant Address | Suite 106, 50 West 75th Street, Willowbrook, Illinois, United States, 60527 A company incorporated under the laws of United States of America |
| Jurisdiction | DELHI |
| Agent | LUTHRA & LUTHRA LAW OFFICES |
| Agent Address | 103 ASHOKA ESTATE 24 BARAKHAMBA ROAD, NEW DELHI-1 |
Frequently Asked Questions
What is the status of trademark REVNEUZEPriority claimed from 30/07/2019; Application No. : 88550791 ;United States of America? ▾
The trademark application number 4252323 is currently marked as "DRAFT" in the official trademark registry.
Who is the owner of trademark REVNEUZEPriority claimed from 30/07/2019; Application No. : 88550791 ;United States of America? ▾
The trademark application number 4252323 is owned by PHARMAZZ, INC..
Which class does trademark REVNEUZEPriority claimed from 30/07/2019; Application No. : 88550791 ;United States of America belong to? ▾
Trademark application number 4252323 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 4252323? ▾
The trademark agent associated with application number 4252323 is LUTHRA & LUTHRA LAW OFFICES.
Was trademark REVNEUZEPriority claimed from 30/07/2019; Application No. : 88550791 ;United States of America published in the journal? ▾
Yes, trademark application number 4252323 was published in Journal No. 1919.
What is trademark REVNEUZEPriority claimed from 30/07/2019; Application No. : 88550791 ;United States of America? ▾
Trademark application number 4252323 relates to "pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's disease, parkinson's disease, mixed dementia, frontotemporal dementia, dementia with lewy bodies, vascular dementia, wernicke-korsakoff syndrome, huntington's disease, creutzfeldt jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified